We conducted an analysis of two distinct cohorts and revealed a correlation between CD2AP rs9296559 and higher CSF total tau (t-tau) and phosphorylated tau (p-tau) levels in patients with mild cognitive impairment [13]. The gene discussed is MAPT; the disease is Cognitive impairment.